BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 38164268)

  • 21. A potent multifunctional ZIF-8 nanoplatform developed for colorectal cancer therapy by triple-delivery of chemo/radio/targeted therapy agents.
    Iranpour S; Bahrami AR; Dayyani M; Saljooghi AS; Matin MM
    J Mater Chem B; 2024 Jan; 12(4):1096-1114. PubMed ID: 38229578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo.
    Jiang Z; Wang Y; Sun L; Yuan B; Tian Y; Xiang L; Li Y; Li Y; Li J; Wu A
    Biomaterials; 2019 Mar; 197():41-50. PubMed ID: 30640136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery.
    Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H
    Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel catalytic micromotor of porous zeolitic imidazolate framework-67 for precise drug delivery.
    Wang L; Zhu H; Shi Y; Ge Y; Feng X; Liu R; Li Y; Ma Y; Wang L
    Nanoscale; 2018 Jun; 10(24):11384-11391. PubMed ID: 29877544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acidic Environment-Responsive Metal Organic Framework-Mediated Dihydroartemisinin Delivery for Triggering Production of Reactive Oxygen Species in Drug-Resistant Lung Cancer.
    Yan X; Zhao X; Fan M; Zheng W; Zhu G; Li B; Wang L
    Int J Nanomedicine; 2024; 19():3847-3859. PubMed ID: 38708182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release.
    Chen J; Liu J; Hu Y; Tian Z; Zhu Y
    Sci Technol Adv Mater; 2019; 20(1):1043-1054. PubMed ID: 31723371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesoporous iron-carboxylate metal-organic frameworks synthesized by the double-template method as a nanocarrier platform for intratumoral drug delivery.
    Wu Z; Hao N; Zhang H; Guo Z; Liu R; He B; Li S
    Biomater Sci; 2017 May; 5(5):1032-1040. PubMed ID: 28358402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycyrrhetinic Acid Receptor-Mediated Zeolitic Imidazolate Framework-8 Loaded Doxorubicin as a Nanotherapeutic System for Liver Cancer Treatment.
    Mi X; Lou Y; Wang Y; Dong M; Xue H; Li S; Lu J; Chen X
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation and biological evaluation of antibody targeted metal-organic framework drug delivery system (TDDS) in Her2 receptor-positive cells.
    Chen Q; Zhang XN; Ding GY; Ma YF; Zhou MS; Zhang Y
    Talanta; 2024 Mar; 269():125380. PubMed ID: 37995639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
    Li Y; Hou H; Zhang P; Zhang Z
    Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoscale Metal-Organic-Frameworks Coated by Biodegradable Organosilica for pH and Redox Dual Responsive Drug Release and High-Performance Anticancer Therapy.
    Ren SZ; Zhu D; Zhu XH; Wang B; Yang YS; Sun WX; Wang XM; Lv PC; Wang ZC; Zhu HL
    ACS Appl Mater Interfaces; 2019 Jun; 11(23):20678-20688. PubMed ID: 31081332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phosphorylcholine-based zwitterionic copolymer coated ZIF-8 nanodrug with a long circulation time and charged conversion for enhanced chemotherapy.
    Xie R; Yang P; Peng S; Cao Y; Yao X; Guo S; Yang W
    J Mater Chem B; 2020 Jul; 8(28):6128-6138. PubMed ID: 32568335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromium-Doped Zinc Gallogermanate@Zeolitic Imidazolate Framework-8: A Multifunctional Nanoplatform for Rechargeable In Vivo Persistent Luminescence Imaging and pH-Responsive Drug Release.
    Lv Y; Ding D; Zhuang Y; Feng Y; Shi J; Zhang H; Zhou TL; Chen H; Xie RJ
    ACS Appl Mater Interfaces; 2019 Jan; 11(2):1907-1916. PubMed ID: 30566326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fe
    He M; Zhou J; Chen J; Zheng F; Wang D; Shi R; Guo Z; Wang H; Chen Q
    J Mater Chem B; 2015 Dec; 3(46):9033-9042. PubMed ID: 32263034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manganese Dioxide Nanoplatform with a Hollow Rhombic Dodecahedron Morphology for Drug Delivery.
    Zhang Z; Yu D; Sui D; Shi M; Wang K; Zhang Y; Ji Y
    ACS Appl Bio Mater; 2024 Feb; 7(2):1169-1178. PubMed ID: 38253011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-Penetrating Peptidic GRP78 Ligand-Conjugated Iron Oxide Magnetic Nanoparticles for Tumor-Targeted Doxorubicin Delivery and Imaging.
    Hasani M; Jafari S; Akbari Javar H; Abdollahi H; Rashidzadeh H
    ACS Appl Bio Mater; 2023 Mar; 6(3):1019-1031. PubMed ID: 36862384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells.
    Fan Q; Zuo J; Tian H; Huang C; Nice EC; Shi Z; Kong Q
    J Exp Clin Cancer Res; 2022 May; 41(1):162. PubMed ID: 35501823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering silk sericin decorated zeolitic imidazolate framework-8 nanoplatform to enhance chemotherapy.
    Li X; Hou S; Chen J; He CE; Gao YE; Lu Y; Jia D; Ma X; Xue P; Kang Y; Xu Z
    Colloids Surf B Biointerfaces; 2021 Apr; 200():111594. PubMed ID: 33561693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of dual chemotherapeutic drug delivery system based on metal-organic framework platform in enhancing tumor regression for breast cancer research.
    Zhan L; Yin X; Qiu L; Li C; Wang Y
    Biochem Biophys Res Commun; 2024 May; 710():149889. PubMed ID: 38581955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mineralization of pH-Sensitive Doxorubicin Prodrug in ZIF-8 to Enable Targeted Delivery to Solid Tumors.
    Yan J; Liu C; Wu Q; Zhou J; Xu X; Zhang L; Wang D; Yang F; Zhang H
    Anal Chem; 2020 Aug; 92(16):11453-11461. PubMed ID: 32664723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.